Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chromosome 1q21.1 duplication syndrome is a rare condition caused by the presence of an extra copy of a small piece of chromosome 1 in the cells of the body. Signs and symptoms can vary widely among affected individuals. Some individuals have no symptoms, while others may have features such as a large head size (macrocephaly); mild to moderate developmental delay and learning difficulties; autism or autistic-like behavior; heart problems; seizures; and/or and distinctive facial features. This condition can occur sporadically as a de novo mutation (by chance) or can be inherited in an autosomal dominant manner from a parent. Treatment depends on the signs and symptoms present in each individual.
Features include very common findings: Intellectual disability and Global developmental delay; and common findings: Hypertelorism, Frontal bossing, and Macrocephaly. 29 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 7 | Mild intellectual disability, Seizure, Specific learning disability |
Phenotype severity distribution: 2 very common features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for chromosome 1q21.1 duplication syndrome. Research spans Epidemiology / Natural History (50%), Case Report / Case Series (25%), and Clinical Trial Publication (25%).
Carrasco Salas P (2025). [PMID: 41230204](https://pubmed.ncbi.nlm.nih.gov/41230204/). *Mol Syndromol*. [Epidemiology / Natural History]
Minelli M (2025). [PMID: 39852141](https://pubmed.ncbi.nlm.nih.gov/39852141/). *Curr Issues Mol Biol*. [Case Report / Case Series]
Miyamoto T (2025). [PMID: 40515658](https://pubmed.ncbi.nlm.nih.gov/40515658/). *Psychiatry Clin Neurosci*. [Epidemiology / Natural History]
Perović D (2024). [PMID: 40070860](https://pubmed.ncbi.nlm.nih.gov/40070860/). *Balkan J Med Genet*. [Clinical Trial Publication]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 11:13 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chromosome 1q21.1 duplication syndrome
Eyes
3 |
Strabismus, Glaucoma, Cataract |
Muscles | 2 | Low muscle tone (hypotonia), Joint stiffness present at birth (arthrogryposis multiplex congenita) |
Head and neck | 1 | Macrocephaly |
Growth and development | 1 | Failure to thrive |
Digestive system | 1 | Gastroesophageal reflux |